Evidence map›Paper›PMID 28638447›Full record

ArticleJournal of Cancer2017

Serum IgG4:IgG Ratio Predicts Recurrence of Patients with Hepatocellular Carcinoma after Curative Resection.

Jiong Wu, Xiao-Lu Ma, Lu Tian, Chun-Yan Zhang, Bei-Li Wang, Yu-Yi Hu, Xing-Hui Gao, Yan Zhou, Min-Na Shen, Yin-Fei Peng and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Jiong WuDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Xiao-Lu MaDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Lu TianDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Chun-Yan ZhangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Bei-Li WangDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Yu-Yi HuDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Xing-Hui GaoDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Yan ZhouDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Min-Na ShenDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Yin-Fei PengDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Bai-Shen PanDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Jian ZhouDepartment of Liver Surgery, Liver Cancer Institute, Zhongshan hospital, Fudan University, Shanghai 200032, P. R. China.
Jia FanDepartment of Liver Surgery, Liver Cancer Institute, Zhongshan hospital, Fudan University, Shanghai 200032, P. R. China.
Xin-Rong YangDepartment of Liver Surgery, Liver Cancer Institute, Zhongshan hospital, Fudan University, Shanghai 200032, P. R. China.
Wei GuoDepartment of Laboratory Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, P. R. China.
Fudan University · CNSun Yat-sen University · CNThe First Affiliated Hospital, Sun Yat-sen University · CNZhongshan Hospital · CN

Funding

Selectively targeting delta opioid receptor subtypes to control drinking behaviorR01AA020401 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WHISTLER, JENNIFER L · 2011 to 2015
$1.8M
NIAAA NIH HHS R01 AA020401
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

curative resectionHepatocellular carcinomaIgG4prognosisrecurrenceserum biomarkersTh1-to-Th2 switch.

Identifiers

PMID28638447
PMCPMC5479238
OpenAlexW2619827812

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.